Clinical Trial Update: Study to Evaluate Drug-Drug Interaction Between IDX719 and Simeprevir in Healthy Participants (MK-1894-004) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the drug-drug interaction between IDX719 and simeprevir in healthy participants; related to Chronic Hepatitis C Infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• IDX719 (NS5A inhibitor)
• Simeprevir (simeprevir)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Chronic Hepatitis C Infection | Phase 1 | Status: COMPLETED